We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Guidant, Boston Scientific Take Heart In Merger Approval

Law360 (April 6, 2006, 12:00 AM EDT) -- After winning overwhelming approval from shareholders last week, Boston Scientific Corp. has won antitrust clearance from the Federal Trade Commission, pumping new blood into the long-awaited merger between the medical device maker and its rival Guidant.

Boston Scientific said that while the agreement is subject to final review and approval by the FTC, all outstanding antitrust issues related to the proposed Guidant transaction have been resolved.

The medical device maker also announced that pursuant to antitrust law, it will voluntarily withdraw and re-file its notification in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.